AM-3005

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameAM-3005
Drug Alias Namebacterial protein synthesis inhibitor (Kyorin)mutilin-quinolone hybrid antibiotic (Kyorin)topoisomerase II inhibitor (Kyorin)AM-3005
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial proteins synthesis inhibitorsTopoisomerase II inhibitors
TargetsTopoisomerase IIBacterial proteins
Therapy Area/IndicationsGram-Positive Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyorin Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyorin Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsGram-Positive Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A